Radiation before surgery for recurrent adrenal cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether giving radiation before surgery helps people with adrenal cancer that has come back after previous treatment. It aims to see if this approach can improve outcomes for patients who can have surgery at the NIH.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your adrenal cancer has come back and can be removed with surgery.
- You are well enough to have both radiation and surgery.
- You agree to have a tumor biopsy before starting treatment.
- You have not had radiation to the belly area before.
- You are not pregnant and agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving radiation therapy after surgery for adrenocortical carcinoma (a rare cancer of the adrenal gland) can improve outcomes compared to just watching and waiting. It is for patients who have certain high-risk features that make the cancer more likely to come back.
This trial tests whether adding a type of immunotherapy (pembrolizumab) to targeted radiation can help people with adrenal cancer that has spread to the liver. It aims to shrink tumors and slow the cancer's growth.
This study looks at whether giving mitotane after surgery (and possibly adding cisplatin/etoposide chemotherapy) helps prevent adrenal cancer from coming back. It is for people with stage I–III adrenal cortical cancer who have a high risk of relapse after their tumor was removed.
This trial tests a combination of an immunotherapy drug (PD-1 antibody) and radiation therapy for people with adrenal cortical carcinoma that has come back or spread and can't be removed with surgery. The goal is to see if this combination can help shrink or control the cancer when other treatments have stopped working.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial tests a new way of delivering radiation for prostate cancer that has come back after prostate surgery. It may help control the cancer by targeting the “prostate bed” area or nearby lymph nodes where it returned.
Hear when a new Adrenocortical Carcinoma (ACC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.